Human Endothelial Cell Activation by Escherichia coli and Staphylococcus aureus Is Mediated by TNF and IL-1β Secondarily to Activation of C5 and CD14 in Whole Blood

The Journal of Immunology : Official Journal of the American Association of Immunologists
Stig NymoT E Mollnes

Abstract

Endothelial cells (EC) play a central role in inflammation. E-selectin and ICAM-1 expression are essential for leukocyte recruitment and are good markers of EC activation. Most studies of EC activation are done in vitro using isolated mediators. The aim of the present study was to examine the relative importance of pattern recognition systems and downstream mediators in bacteria-induced EC activation in a physiological relevant human model, using EC incubated with whole blood. HUVEC were incubated with human whole blood. Escherichia coli- and Staphylococcus aureus-induced EC activation was measured by E-selectin and ICAM-1 expression using flow cytometry. The mAb 18D11 was used to neutralize CD14, and the lipid A analog eritoran was used to block TLR4/MD2. C5 cleavage was inhibited using eculizumab, and C5aR1 was blocked by an antagonist. Infliximab and canakinumab were used to neutralize TNF and IL-1β. The EC were minimally activated when bacteria were incubated in serum, whereas a substantial EC activation was seen when the bacteria were incubated in whole blood. E. coli-induced activation was largely CD14-dependent, whereas S. aureus mainly caused a C5aR1-mediated response. Combined CD14 and C5 inhibition reduced E-selectin ...Continue Reading

References

Sep 1, 1994·The Journal of Clinical Investigation·K E ForemanP A Ward
Apr 4, 2002·Trends in Immunology·Tom E MollnesJohn D Lambris
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
May 13, 2008·Journal of Biomedical Materials Research. Part a·Fredrik BexbornKristina Nilsson Ekdahl
Jul 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katie L Lloyd-JonesPaul Kubes
Aug 19, 2009·Biochemical and Biophysical Research Communications·Himanshu KumarShizuo Akira
Aug 28, 2009·Innate Immunity·Anita SchildbergerDieter Falkenhagen
Sep 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Knut Tore LappegårdTom Eirik Mollnes
Oct 21, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ebbe Billmann ThorgersenTom Eirik Mollnes
Apr 9, 2010·Science Translational Medicine·Nyall R LondonDean Y Li
Aug 17, 2011·Seminars in Immunopathology·Victor W M van Hinsbergh
Aug 31, 2011·Blood Purification·Anita SchildbergerDieter Falkenhagen
Dec 23, 2011·Current Opinion in Microbiology·Mark Harding, Paul Kubes
Aug 24, 2013·Journal of Hematology & Oncology·Jietang MaiXiao-Feng Yang
Sep 26, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Corinna LauTom Eirik Mollnes
Nov 26, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Helong ZhaoRamesh K Ganju
Feb 7, 2014·Annual Review of Immunology·V Michael Holers
Feb 12, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Espen W SkjefloTom E Mollnes
May 3, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Markus Huber-LangTom E Mollnes
Jun 22, 2014·Molecular Immunology·Marco Di Gioia, Ivan Zanoni
Nov 15, 2014·Nature Reviews. Immunology·Martin KolevClaudia Kemper
Apr 25, 2015·Clinical and Experimental Immunology·Kjetil H EggeTom E Mollnes

❮ Previous
Next ❯

Citations

Jul 9, 2016·Current Opinion in Immunology·Steven G ReedMark T Orr
Oct 6, 2018·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Jihye KimEun-Gyung Cho
Apr 7, 2020·Expert Opinion on Therapeutic Targets·Jason K KarimyKristopher T Kahle
Mar 27, 2020·Journal of Molecular Recognition : JMR·Svetlana N PleskovaAlexander S Erofeev
Apr 14, 2020·Current Pharmaceutical Design·Konstantinos MourouzisDimitris Tousoulis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.